{"id":"tp-45044","type":"article-newspaper","title":"Eagle Pharmaceuticals Extends Stockholder Rights Plan Through 2027","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/45044","datePublished":"2026-10-30T19:10:01.000Z","dateModified":"2026-10-30T19:10:01.000Z","language":"en","abstract":"The plan’s rights may be triggered at 10% beneficial ownership, or 15% for covered passive institutional investors.","section":"Business","references":[]}